Self-reactive B cells are not eliminated or inactivated by autoantigen expressed on thyroid epithelial cells

Journal of Experimental Medicine

Volumn 186, Issue 12, 1997, Pages 2005-2012

  Akkaraju, Srinivas ^a   Canaan, Karen ^a   Goodnow, Christopher C ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b Biology and Environment   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; EPITHELIUM CELL; GRAVES DISEASE; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THYROID CELL; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; AUTOANTIGENS; B-LYMPHOCYTES; EPITHELIAL CELLS; IMMUNE TOLERANCE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MURAMIDASE; THYROID GLAND; THYROIDITIS, AUTOIMMUNE;

EID: 0031468121     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.12.2005     Document Type: Article

References (38)

1. Peter, J.B., and Y. Shoenfeld, editors. 1996. Autoantibodies. Elsevier, Oxford. 1-853.
2. Weetman, A.P., and A.M. McGregor. 1994. Autoimmune thyroid disease: further developments in our understanding. Endocr. Rev. 15:788-830.
3. Richman, D.P., and M.A. Agius. 1994. Myasthenia gravis: pathogenesis and treatment. Semin. Neurol. 14:106-110.
4. Nousari, H.C., and G.J. Anhalt. 1995. Bullous skin diseases. Curr. Opin. Immunol. 7:844-852.
5. Kelly, P.T., and E.F. Haponik. 1994. Goodpasture syndrome: molecular and clinical advances. Medicine (Balt.). 73:171-185.
6. Goodnow, C.C., J. Crosbie, S. Adelstein, T.B. Lavoie, S.J. Smith-Gill, R.A. Brink, H. Pritchard-Briscoe, J.S. Wotherspoon, R.H. Loblay, K. Raphael et al. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature. 334:676-682.
7. Nemazee, D.A., and K. Burki. 1989. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature. 337:562-566.
8. Erikson, J., M.Z. Radic, S.A. Camper, R.R. Hardy, C. Carmack, and M. Weigert. 1991. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature. 349:331-334.
9. Hartley, S.B., J. Crosbie, R. Brink, A.B. Kantor, A. Basten, and C.C. Goodnow. 1991. Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature. 353:765-769.
10. Okamoto, M., M. Murakami, A. Shimizu, S. Ozaki, T. Tsubata, S. Kumagai, and T. Honjo. 1992. A transgenic model of autoimmune hemolytic anemia. J. Exp. Med. 175: 71-79.
11. Hartley, S.B., and C.C. Goodnow. 1994. Censoring of self-reactive B cells with a range of receptor affinities in transgenic mice expressing heavy chains for a lysozyme-specific antibody. Int. Immunol. 6:1417-1425.
12. Lang, J., M. Jackson, L. Teyton, A. Brunmark, K. Kane, and D. Nemazee. 1996. B cells are exquisitely sensitive to central tolerance and receptor editing induced by ultralow affinity, membrane-bound antigen. J. Exp. Med. 184:1685-1697.
13. Paterson, P.Y. 1966. Experimental allergic encephalomyelitis and autoimmune disease. Adv. Immunol. 5:131-208.
14. Weigle, W.O. 1980. Analysis of autoimmunity through experimental models of thyroiditis and allergic encephalomyelitis. Adv. Immunol. 30:159-273.
15. Russell, D.M., Z. Dembic, G. Morahan, J.F. Miller, K. Burki, and D. Nemazee. 1991. Peripheral deletion of self-reactive B cells. Nature. 354:308-311.
16. Miller, J.F.A.P., W.R. Heath, J. Allison, G. Morahan, M. Hoffman, C. Kurts, and H. Kosaka. 1997. T cell tolerance and autoimmunity. In The Molecular Basis of Cellular Defence Mechanisms. Vol. 204. G.R. Bock and J.A. Goode, editors. John Wiley and Sons, Chichester. 159-171.
17. Wilson, J.D., and D.W. Foster, editors. 1992. Williams Textbook of Endocrinology. 8th edition. W.B. Saunders Company, Philadelphia.
18. Vladutiu, A.O., and N.R. Rose. 1971. Autoimmune murine thyroiditis relation to histocompatibility (H-2) type. Science. 174:1137-1139.
19. Okayasu, I., Y. Hara, K. Nakamura, and N.R. Rose. 1994. Racial and age-related differences in incidence and severity of focal autoimmune thyroiditis. Am. J. Clin. Pathol. 101:698-702.
20. Musti, A.M., V.M. Ursini, E.V. Avvedimento, V. Zimarino, and R. Di Lauro. 1987. A cell type specific factor recognizes the rat thyroglobulin promoter. Nucleic Acids Res. 15:8149-8166.
21. Mason, D.Y., M. Jones, and C.C. Goodnow. 1992. Development and follicular localization of tolerant B lymphocytes in lysozyme/anti-lysozyme IgM/IgD transgenic mice. Int. Immunol. 4:163-175.
22. Foster, H.L., J.D. Small, and J.G. Fox, editors. 1983. The Mouse in Biomedical Research. Vol. III. Academic Press, New York.
23. Barbee, R.W., B.D. Perry, R.N. Re, and J.P. Murgo. 1992. Microsphere and dilution techniques for the determination of blood flows and volumes in conscious mice. Am. J. Physiol. 263:R728-733.
24. Musti, A.M., E.V. Avvedimento, C. Polistina, V.M. Ursini, S. Obici, L. Nitsch, S. Cocozza, and R. Di Lauro. 1986. The complete structure of the rat thyroglobulin gene. Proc. Natl. Acad. Sci. USA. 83:323-327.
25. Akkaraju, S., W.Y. Ho, D. Leong, K. Canaan, M.M. Davis, and C.C. Goodnow. 1997. A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity. 7:255-271.
26. Allison, J., I.L. Campbell, G. Morahan, T.E. Mandel, L.C. Harrison, and J.F. Miller. 1988. Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells. Nature. 333:529-533.
27. Turnley, A.M., G. Morahan, H. Okano, O. Bernard, K. Mikoshiba, J. Allison, P.P. Bartlett, and J.F. Miller. 1991. Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes [see comments]. Nature. 353:566-569.
28. Frauman, A.G., P. Chu, and L.C. Harrison. 1993. Nonimmune thyroid destruction results from transgenic overexpression of an allogeneic major histocompatibility complex class I protein. Mol. Cell. Biol. 13:1554-1564.
29. Picker, L.J., and E.C. Butcher. 1992. Physiological and molecular mechanisms of lymphocyte homing. Annu. Rev. Immunol. 10:561-591.
30. Wheater, P.R., H.G. Burkitt, and V.G. Daniels. 1987. Functional Histology. 2nd edition. Churchill Livingstone, Edinburgh. 348 pp.
31. Waldmann, T., and W. Strober. 1969. Metabolism of immunoglobulins. Progr. Allergy. 13:1-110.
32. Kennel, S.J., R. Falcioni, and J.W. Wesley. 1991. Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts. Cancer Res. 51:1529-1536.
33. Kennel, S.J. 1992. Effects of target antigen competition on distribution of monoclonal antibody to solid tumors. Cancer Res. 52:1284-1290.
34. Tandon, N., B.P. Morgan, and A.P. Weetman. 1992. Expression and function of membrane attack complex inhibitory proteins on thyroid follicular cells. Immunology. 75:372-377.
35. Tandon, N., S.L. Yan, B.P. Morgan, and A.P. Weetman. 1994. Expression and function of multiple regulators of complement activation in autoimmune thyroid disease. Immunology. 81:643-647.
36. Kotani, T., K. Umeki, K. Hirai, and S. Ohtaki. 1990. Experimental murine thyroiditis induced by porcine thyroid peroxidase and its transfer by the antigen-specific T cell line. Clin. Exp. Immunol. 80:11-18.
37. Tang, H., C. Bedin, B. Texier, and J. Charreire. 1990. Autoantibody specific for a thyroglobulin epitope inducing experimental autoimmune thyroiditis or its anti-idiotype correlates with the disease. Eur. J. Immunol. 20:1535-1539.
38. Carayanniotis, G., G.C. Huang, L.B. Nicholson, T. Scott, P. Allain, A.M. McGregor, and J.P. Banga. 1995. Unaltered thyroid function in mice responding to a highly immunogenic thyrotropin receptor: implications for the establishment of a mouse model for Graves' disease. Clin. Exp. Immunol. 99: 294-302.